Skip Navigation HRSA - U.S Department of Health and Human Services, Health Resources and Service Administration U.S. Department of Health & Human Services
Home
Questions
Order Publications
 
Grants Find Help Service Delivery Data Health Care Concerns About HRSA

Pharmacy Affairs & 340B Drug Pricing Program

 

Current Issues

340B Prime Vendor Apexus Announces $2 Million Shareback Program for Eligible Participants (Nov. 14, 2008)

US Department of Justice’s settlement with Cephalon – As part of the settlement, 340B Covered Entities will be receiving approximately $1.8 million. Cephalon Settlement Agreement and Cephalon News Release from DOJ (October 2, 2008)

Bayer Letter - Regarding the Yasmin® Limited Distribution System (September 30, 2008)

Emergency Prescription Assistance Program (EPAP) – Ike Activation (PDF - 29.57KB) (September 12, 2008)

HHS Provides Prescription Drug and Durable Medical Equipment Assistance for Uninsured Texas Victims of Hurricane Ike (September 12, 2008)

Emergency Prescription Assistance Program (EPAP) - Gustav Activation (PDF - 55KB) (Revised 9/10/2008)

HHS Press Release - HHS Provides Prescription Drug and Durable Medical Equipment Assistance for Uninsured Louisiana Victims of Hurricane Gustav (September 6, 2008)

Warner-Chilcott Letter - 340B Pricing Errors (September 5, 2008)

Dear Manufacturer Letters

VA Will Exempt Inpatient Generic and OTC 340B Sales from FSS Reporting
The Office of Pharmacy Affairs has been notified that the Department of Veterans Affairs (VA) will allow pharmaceutical manufacturers to exclude the sale of 340B inpatient generic and over-the-counter (OTC) drugs from their Federal Supply Schedule (FSS) reporting requirements. As a result, manufacturers may now offer 340B discounts on inpatient generic and OTC drugs without affecting the prices that they are required to provide to FSS.

VA letter to Manufacturers dated July 8, 2004 (Acrobat/pdf) 07/08/2004 and a
Sample request for a "hold harmless" letter (Text File)
As of this date, the OPA has received hold harmless letters from:
Pharmion Corp., Boulder, CO (Labeler code 67211)
Bedford Laboratories, Bedford, OH (Labeler code 55390)
Bausch & Lomb, Tampa, FL (Labeler code 24208)
Eisai, Inc., Woodcliff, NJ (Labeler code 58063)
Élan Pharmaceuticals, Inc., South San Francisco, CA (Labeler code 51479)
This list will be updated as additional hold harmless letters are received.

non-Federal Average Manufacturer Price Calculation

Archived Information